Medicines Optimisation Centricity – Getting It Right

Medicines Optimisation Centricity – Getting It Right

Petersfield, Hampshire, 01 November 2023, Aspire Pharma Ltd initiated and funded the set-up of a series of round table events to discuss Medicines Optimisation Centricity. These events, facilitated by Wilmington Healthcare, as a data intelligence agency, brought together a number of NHS thought leaders from a wide range of disciplines, and led to the creation of a White Paper on medicines optimisation.

The White Paper focuses on the NHS’ approach to providing engagement, choice, and access to medicines in a timely manner. There is a need for the NHS and pharmaceutical businesses to work collaboratively to ensure a patient centric approach is established, with a shared understanding of individual patients. With the right resources, tools, and knowledge, we can help lift barriers in patient care.

Medicines optimisation looks at the value medicines deliver; that they are both clinically and cost effective. Ensuring patients get the correct medicine, and dose, for the correct indication¹, is not always easy. Effective medicines optimisation requires a collaborative approach by those responsible for delivering healthcare to the patient, including the patient themselves¹.

Aspire has long sought to identify opportunities which bring innovative solutions for the benefit of patients, using their expertise to develop strong partnerships with payors, providers, and healthcare professionals.

Together, these partnerships can help deliver a breadth and depth of knowledge to assist in customer and patient centricity, that meets the unmet needs of every patient; thus, making a difference in the lives of patients­­­­ through the development and supply of innovative products and medicines throughout the world.

Richard Condon, CEO at Aspire said: “I would like to congratulate our partners involved in the Medicines Optimisation Centricity Project, which is an excellent example of where we have identified a problem, become co-partners, and worked collaboratively at the highest levels to find a solution.

“This project puts patient care at the top of the agenda and will help lead to better access, value and choice for the NHS.”

The Meds Ops Centricity – It’s Time to Optimise Medicines Optimisation White Paper can be found at: https://www.hsj.co.uk/integrated-care/its-time-to-optimise-medicines-optimisation/7034815.article#.ZG98K1eQAU4.linkedin.

Here is a direct link to the White Paper: https://meds-ops-centricity.co.uk/

Aspire Pharma initiated and funded the set-up of a series of round table events to discuss Medicines Optimisation Centricity. This led to the creation of a White Paper on medicines optimisation. Aspire had no input into the content of the White Paper and reviewed it for factual accuracy and compliance checks only.

References

1.      https://www.england.nhs.uk/medicines-2/medicines-optimisation/